Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2002357043 (hide)

Owner Merck & Co., Inc.

Inventors Fraley, Mark, E.; Garbaccio, Robert, M.

Agent Spruson & Ferguson

Pub. Number AU-B-2002357043

PCT Number PCT/US02/38312

PCT Pub. Number WO2003/049678

Priority 60/338,379 06.12.01 US

Filing date 2 December 2002

Wipo publication date 23 June 2003

Acceptance publication date 24 April 2008

International Classifications

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/4465 (2006.01) - only substituted in position 4

A61K 31/4535 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61K 31/5513 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 239/70 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 487/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 60/338,379 06.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002357043

24 April 2008 Application Accepted

  Published as AU-B-2002357043

21 August 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

30 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002357044-NUCLEIC ACID MOLECULES FROM RICE ENCODING PROTEINS FOR ABIOTIC STRESS TOLERANCE, ENHANCED YIELD, DISEASE RESISTANCE AND ALTERED NUTRITIONAL QUALITY AND USES THEREOF

2002357042-METHOD AND SYSTEM FOR REPLACING LOST OR DELAYED DATA IN SONET/SDH EMULATION PROTOCOLS